@FierceMedDev: Alere warned by FDA for cardio Dx quality shortfalls. Item | Follow @FierceMedDev
@MarkHFierce: A Senate report blasts Medtronic for improperly shaping data regarding its Infuse bone graft, all to boost sales. Story | Follow @MarkHFierce
@DamianFierce: 2012 was less than a banner year for med device and diagnostic IPOs. We take a look at the numbers: Report | Follow @DamianFierce
> Drug wholesaler McKesson ($MCK) will buy medical products distributor PSS World Medical ($PSSI) for $1.46 billion in a bid to beef up its surgical devices supply business. Story
> NeuroMetrix ($NURO), a maker of devices that diagnose and treat neurological complications from diabetes, reported more than $1.7 million in revenue during its fiscal 2012 third quarter, down from over $2.5 million reported during the same period in 2011. Item
> Medical device-related mergers and acquisitions activity declined drastically in the 2012 third quarter, as part of a larger decline in the overall health care industry, according to Irving Levin Associates. Item
> Elixir Medical says it completed enrollment in a 120-patient pivotal trial testing its DESolve drug eluting bioresorbable coronary scaffold system--which should be resorbed back into the body within two years of implantation. Release
> Teleflex ($TFX) inked a two-year extension of a deal with Novation for it to keep offering a line of laryngoscopes and related accessories. Release
> The U.K.'s HeartSine Technologies issued a global correction of its Samaritan 300/300P public access defibrillators because some of the devices may not work right due to battery defects. Item
> Rapid Pathogen Screening used technology designed to detect explosives to develop a rapid test for conjunctivitis, or pink eye. Story
> Researchers believe they've developed an electronic "nose," used to detect molecules in a patient's breath, to diagnose obstructive sleep apnea. Details are published in the European Respiratory Journal. Release
Biotech News
@FierceBiotech: From FierceBiotechIT.com: Swedish bioinformatics group grabs $840K to fuel growth, report says. More | Follow @FierceBiotech
@JohnCFierce: Signs of life? Top 10 biotech IPOs. Special Report | Follow @JohnCFierce
@RyanMFierce: GSK's SROne leads $35M round for Thrasos Therapeutics for PhII study of kidney injury treatment. Release | Follow @RyanMFierce
> Ex-Geron chief spearheads bid to revive mothballed stem cell studies. News
> Shire chief prepares to hand over reins to hand-picked successor. Story
> Profit plunge stokes M&A buzz as AstraZeneca chief vows to strike more deals. Report
Pharma News
@FiercePharma: Novartis puts off restart at Lincoln, Neb., plant... again. Fed-up CEO says no more predictions--Bloomberg. News | Follow @FiercePharma
> What's AZ's new CEO thinking? Let's parse his words. Story
> Gilenya, Afinitor among bright spots in flat Novartis quarter. Article
> Novartis plant delay, vaccine woes steal spotlight. More
Vaccines News
@AlisonBFierce: U. of Texas at Austin researchers got $6.5M from Dept. of Defense to develop new vaccines for emerging health threats. More | Follow @AlisonBFierce
> Italy bans Novartis influenza vaccines. News
> CDC green-lights GSK's meningitis vaccine for at-risk infants. Item
> HIV antibody development discovery advances vaccine search. Story
> EMA: 'Insufficient' link between narcolepsy and GSK flu vaccine. Report
> Novavax reports positive avian flu vaccine results. Article
Pharma Manufacturing News
> DSM snags another project to feed Australian biologics plant. More
> Novartis CEO defends manufacturing lapses. Article
> FDA group argues for helping poor countries beef up oversight. Story